Exact Sciences (EXAS)
(Real Time Quote from BATS)
$59.40 USD
-3.84 (-6.07%)
Updated Apr 25, 2024 11:22 AM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -204.15 | -623.51 | -595.63 | -848.53 | -83.99 |
Depreciation/Amortization & Depletion | 207.23 | 222.50 | 211.86 | 447.17 | 84.93 |
Net Change from Assets/Liabilities | -0.34 | -26.38 | 111.11 | -42.73 | -53.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 153.38 | 203.83 | 170.42 | 580.58 | -62.39 |
Net Cash From Operating Activities | 156.12 | -223.56 | -102.24 | 136.48 | -115.01 |
Property & Equipment | -124.69 | -189.46 | -193.84 | -475.77 | -171.80 |
Acquisition/ Disposition of Subsidiaries | -52.41 | -14.69 | -499.73 | -6.66 | -973.86 |
Investments | 226.53 | 278.76 | -387.77 | -219.23 | 1,026.44 |
Other Investing Activities | 0.25 | -0.55 | -0.74 | -0.38 | -1.85 |
Net Cash from Investing Activities | 49.68 | 74.07 | -1,082.09 | -702.04 | -121.07 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 31.54 | 32.02 | 37.51 | 907.13 | 17.18 |
Issuance (Repayment) of Debt | 137.98 | 0.00 | 0.00 | 975.49 | 236.12 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -9.75 | 44.47 | -29.04 | -3.01 | -0.12 |
Net Cash from Financing Activities | 159.77 | 76.49 | 8.47 | 1,879.62 | 253.18 |
Effect of Exchange Rate Changes | 1.32 | 0.03 | 0.02 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 366.89 | -72.98 | -1,175.83 | 1,314.07 | 17.10 |
Cash at Beginning of Period | 242.79 | 315.77 | 1,491.59 | 177.53 | 160.43 |
Cash at End of Period | 609.68 | 242.79 | 315.77 | 1,491.59 | 177.53 |
Diluted Net EPS | -1.13 | -3.54 | -3.48 | -5.61 | -0.64 |
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -204.15 | -154.38 | -155.18 | -74.15 |
Depreciation/Amortization & Depletion | NA | 207.23 | 153.06 | 100.80 | 51.54 |
Net Change from Assets/Liabilities | NA | -0.34 | -27.00 | -2.43 | -56.84 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 153.38 | 114.89 | 119.01 | 41.24 |
Net Cash From Operating Activities | NA | 156.12 | 86.57 | 62.21 | -38.22 |
Property & Equipment | NA | -124.69 | -89.27 | -64.08 | -29.36 |
Acquisition/ Disposition of Subsidiaries | NA | -52.41 | -50.00 | 0.00 | 0.00 |
Investments | NA | 226.53 | 255.96 | 214.00 | 112.30 |
Other Investing Activities | NA | 0.25 | -0.25 | -0.50 | 0.00 |
Net Cash from Investing Activities | NA | 49.68 | 116.45 | 149.42 | 82.94 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 31.54 | 19.24 | 18.16 | 0.96 |
Issuance (Repayment) of Debt | NA | 137.98 | 137.98 | 137.98 | 137.98 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -9.75 | -7.48 | -6.50 | -5.34 |
Net Cash from Financing Activities | NA | 159.77 | 149.73 | 149.64 | 133.60 |
Effect of Exchange Rate Changes | NA | 1.32 | -0.63 | 0.61 | 0.55 |
Net Change In Cash & Equivalents | NA | 366.89 | 352.12 | 361.87 | 178.87 |
Cash at Beginning of Period | NA | 242.79 | 242.79 | 242.79 | 242.79 |
Cash at End of Period | NA | 609.68 | 594.91 | 604.66 | 421.66 |
Diluted Net EPS | NA | -0.26 | 0.00 | -0.45 | -0.42 |